Table 2 Basic characteristics of the included studies
From: Systematic review of the economic evaluation model of assisted reproductive technology
Studies included | Countries | Perspective | Study population | Comparators |
|---|---|---|---|---|
Evans 2019 [13] | US | — | Patients receiving fresh/frozen embryo transfer | Different ovulation agents: ①Progesterone: ②Conventional GnRH |
Xue 2019 [14] | Germany | Payer | Patients during an assisted reproductive cycle | Different ovulation agents: â‘ r-FSH: â‘¡r-FSH biosimilars |
Oostingh 2019 [15] | Netherlands | â‘ Health system; â‘¡The whole society | Low fertility couples undergoing IVF for the first time | Different pre-pregnancy care: â‘ mHealth coaching program; â‘¡Usual care |
Jing 2020 [16] | China | Patient | Patients aged 20 to 38 years undergoing their first IVF cycle | Different ovulation induction regiments: â‘ GnRH-a long-protocol; â‘¡GnRH-A protocol |
Kluber 2020 [17] | Germany | Patient | Women who plan to delay pregnancy until after the age of 40 | Different interventions: â‘ oocyte cryopreservation; â‘¡natural conception;â‘¢IVF/ICSI |
Mathieu 2020 [18] | France | — | Women younger than 40 years of age diagnosed with endometriosis and referred for family planning | Different ovulation induction regiments: ①PPOS protocol; ②antagonist protocol |
Sitler 2020 [19] | US | â‘ Patient; â‘¡Payer | Patients aged 20 to 44 undergoing IVF | Different transfer protocols: â‘ SET; â‘¡ DET |
Facadio 2021 [20] | US | Payer | Patients undergoing IVF treatment with fresh donor oocytes | PGT-A |
Lee 2021 [21] | US | â‘ Patient; â‘¡Payer | Women over 18 years of age undergoing their first fresh IVF/ frozen embryo transfer cycle | PGT-A |
van Eekelen 2021 [22] | Netherlands | The whole society | Couples with unexplained low fertility | Different ovulation agents: â‘ CC; â‘¡Letrozole; â‘¢Gonadotrophins |
Cheng 2021 [23] | US | — | Couples who have undergone vasectomy reversal (couples with advanced maternal age) | Different treatment options: ①VR followed by NC; ②SR with IVF; ③VR and SR followed by failed NC and then IVF; ④VR and SR followed by failed IVF and then NC |
Schwarze 2022 [24] | Spain | Health system | Fresh embryo transfer in patients with ART cycles | Different ovulation agents: ①Originator r-hFSHα; ②r-hFSHα biosimilars |